Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyzine for meal-related anxiety in underweight eating disorder patients
NCT01372670Phase 4Withdrawn
- Sponsor
- HealthPartners Institute
- Start
- Jan 2012
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxyzine in anxiety disorder, sponsored by HealthPartners Institute. Planned start Jan 2012; status: withdrawn.
02
Drugs
hydroxyzine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT01372670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01372670.